Wellgistics Health Inc. Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024

Reuters

08/20

<a href="https://laohu8.com/S/WGRX">Wellgistics Health Inc.</a> Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024

Wellgistics Health Inc. (NASDAQ:WGRX) reported financial results for the second fiscal quarter ending June 30, 2025. The company's revenue on a pro forma basis for the first half of 2025 stood at $18.65 million, compared to $18.25 million in the first half of 2024, reflecting a slight increase. Since its initial public offering in February 2025, Wellgistics Health has consolidated its operations, streamlined staffing, and upgraded its ERP system to support growth. The company is also expanding its direct-to-patient programs, leveraging a network of over 6,500 independent pharmacies and 200 manufacturers to enhance its reach in therapeutic areas such as diabetes, weight loss, chronic pain, sleep disorders, and men's and women's health. The CEO emphasized the company's focus on accelerating growth through strategic funding and expanding access via its direct-to-patient delivery models.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1063183) on August 20, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2560106443"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2560106443\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2560106443?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-20 21:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2560106443","market":"fut","top_or_hot":-1,"title":"Wellgistics Health Inc. Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/WGRX\">Wellgistics Health Inc.</a> Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Wellgistics Health Inc. (NASDAQ:WGRX) reported financial results for the second fiscal quarter ending June 30, 2025. The company's revenue on a pro forma basis for the first half of 2025 stood at $18.65 million, compared to $18.25 million in the first half of 2024, reflecting a slight increase. Since its initial public offering in February 2025, Wellgistics Health has consolidated its operations, streamlined staffing, and upgraded its ERP system to support growth. The company is also expanding its direct-to-patient programs, leveraging a network of over 6,500 independent pharmacies and 200 manufacturers to enhance its reach in therapeutic areas such as diabetes, weight loss, chronic pain, sleep disorders, and men's and women's health. The CEO emphasized the company's focus on accelerating growth through strategic funding and expanding access via its direct-to-patient delivery models.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1063183) on August 20, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wellgistics Health Inc. Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWellgistics Health Inc. Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-20 21:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/WGRX\">Wellgistics Health Inc.</a> Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Wellgistics Health Inc. (NASDAQ:WGRX) reported financial results for the second fiscal quarter ending June 30, 2025. The company's revenue on a pro forma basis for the first half of 2025 stood at $18.65 million, compared to $18.25 million in the first half of 2024, reflecting a slight increase. Since its initial public offering in February 2025, Wellgistics Health has consolidated its operations, streamlined staffing, and upgraded its ERP system to support growth. The company is also expanding its direct-to-patient programs, leveraging a network of over 6,500 independent pharmacies and 200 manufacturers to enhance its reach in therapeutic areas such as diabetes, weight loss, chronic pain, sleep disorders, and men's and women's health. The CEO emphasized the company's focus on accelerating growth through strategic funding and expanding access via its direct-to-patient delivery models.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1063183) on August 20, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WGRX","symbol_name":"Wellgistics Health Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL7x0Bz9:1","article_id":"2560106443","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2560106443","pubTimestamp":1755694826,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Wellgistics Health Inc.  reported financial results for the second fiscal quarter ending June 30, 2025. The company's revenue on a pro forma basis for the first half of 2025 stood at $18.65 million, compared to $18.25 million in the first half of 2024, reflecting a slight increase. Since its initial public offering in February 2025, Wellgistics Health has consolidated its operations, streamlined staffing, and upgraded its ERP system to support growth. The company is also expanding its direct-to-patient programs, leveraging a network of over 6,500 independent pharmacies and 200 manufacturers to enhance its reach in therapeutic areas such as diabetes, weight loss, chronic pain, sleep disorders, and men's and women's health. The CEO emphasized the company's focus on accelerating growth through strategic funding and expanding access via its direct-to-patient delivery models.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"WGRX":"Wellgistics Health Inc."},"translate_title":"Wellgistics Health Inc.报告2025年上半年收入为1,865万美元，较2024年上半年的1,825万美元略有增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WGRX":0.9},"content_text":"Wellgistics Health Inc. Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024\n    \n\n        Wellgistics Health Inc. (NASDAQ:WGRX) reported financial results for the second fiscal quarter ending June 30, 2025. The company's revenue on a pro forma basis for the first half of 2025 stood at $18.65 million, compared to $18.25 million in the first half of 2024, reflecting a slight increase. Since its initial public offering in February 2025, Wellgistics Health has consolidated its operations, streamlined staffing, and upgraded its ERP system to support growth. The company is also expanding its direct-to-patient programs, leveraging a network of over 6,500 independent pharmacies and 200 manufacturers to enhance its reach in therapeutic areas such as diabetes, weight loss, chronic pain, sleep disorders, and men's and women's health. The CEO emphasized the company's focus on accelerating growth through strategic funding and expanding access via its direct-to-patient delivery models.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1063183) on August 20, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}